Cost-effectiveness analysis of rasagiline as monotherapy aimed at disease modulation in patients with Parkinson’s disease in Norway [Podium Presentation]

Cost-effectiveness analysis of rasagiline as monotherapy aimed at disease modulation in patients with Parkinson’s disease in Norway [Podium Presentation]

2011 8th World Congress on Health Economics of the International Health Economics Association (IHEA), July 10-13, 2011, Toronto, Canada

Aballea, S. | Vossius, C. | Guelfucci, F. | Brignone, M. | Maehlum, E. | Volume: , Issue: , Pages: , cost-effectiveness analysis, analysis, Disease, Norway, economics,